Pergolide
Back to searchMolecule Structure
Scientific Name
Pergolide
Description of the Drug
Pergolide is a long-acting dopamine agonist that is uncommonly used for the management of Parkinson’s disease, due to the risk for cardiac valvulopathy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01186
http://www.drugbank.ca/drugs/DB01186
Brand Name(s)
Not Available
Company Owner(s)
Strides Pharma Global Pte Ltd, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Valeant Pharmaceuticals International
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine receptor | PROTEIN FAMILY | AGONIST | CHEMBL2096905 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL26921 | |
| PharmGKB | PA450873 | |
| Human Metabolome Database | HMDB0015317 | |
| DrugBank | DB01186 | |
| PubChem: Thomson Pharma | 14874447 | 14825868 |
| PubChem | 47811 | |
| NMRShiftDB | 30100190 | |
| LINCS | LSM-3352 | |
| Nikkaji | J19.083G | |
| BindingDB | 50017543 | 50028421 |
| EPA CompTox Dashboard | DTXSID2023438 | |
| DrugCentral | 2105 | |
| Brenda | 217384 | |
| ChemicalBook | CB4213989 | |
| Guide to Pharmacology | 48 | |
| rxnorm | PERGOLIDE | PERGOLIDE MESYLATE |
| KEGG Ligand | C07425 | |
| ChEBI | 63617 | |
| ZINC | ZINC000003786466 |
